Companies › Thermo Fisher · Global Markets & Policy
Thermo Fisher Scientific Inc.
- NYSE: TMO
US supplier of lab instruments, reagents, research services and drug development and manufacturing services.
Next earnings report: Oct 21, 2026. Thermo Fisher quarterly results and earnings history →
Insider trades (Form 4)
Last 120 days: open-market sales $61.6M, purchases $0. All Thermo Fisher insider transactions →
| Date | Insider | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Gianluca Pettiti President & COO | Open-market sale 10b5-1 plan | 400 | $614.38 | $246K | Form 4 ↗ |
| Aug 31, 2026 | Gianluca Pettiti President & COO | Open-market sale 10b5-1 plan | 3,733 | $614.38 | $2.3M | Form 4 ↗ |
| Aug 24, 2026 | Marc N Casper Chairman & CEO, Director | Open-market sale 10b5-1 plan | 101 | $625.41 | $63K | Form 4 ↗ |
| Aug 24, 2026 | Marc N Casper Chairman & CEO, Director | Open-market sale 10b5-1 plan | 33 | $626.59 | $21K | Form 4 ↗ |
| Aug 24, 2026 | Marc N Casper Chairman & CEO, Director | Open-market sale 10b5-1 plan | 79 | $628.01 | $50K | Form 4 ↗ |
Key financials
| Metric | FY to Dec 2022 | FY to Dec 2023 | FY to Dec 2024 | FY to Dec 2025 |
|---|---|---|---|---|
| Revenue | $44.9B | $42.9B | $42.9B | $44.6B |
| Operating income | $8.4B | $6.9B | $7.3B | $7.7B |
| Net income | — | $6.0B | $6.3B | $6.7B |
| Diluted EPS | $17.63 | $15.45 | $16.53 | $17.74 |
Fiscal years, from annual reports (10-K / 20-F). Source: SEC EDGAR (XBRL company facts), retrieved 2026-10-14. Verify figures against the original filings.
Recent filings
- 2026-07-31 · 10-Q
- 2026-07-23 · 8-K — Results of operations
- 2026-05-26 · 8-K — Shareholder vote results
- 2026-05-01 · 10-Q
- 2026-04-23 · 8-K — Results of operations
- 2026-04-07 · DEF 14A
- 2026-03-24 · 8-K — Other events
- 2026-02-26 · 10-K
Source: SEC EDGAR, retrieved 2026-10-14. Filing types explained: 8-K, 10-Q, 10-K, 20-F / 6-K.
Not investment advice. This page lists official filings and our reports for reference. SignalStack does not rate securities or recommend buying or selling anything.